Table 6 Baseline level of biochemical and inflammatory factors and Demographic and clinical characteristics according to intubation*
From: Serum cystatin C and inflammatory factors related to COVID-19 consequences
Biochemical and Inflammatory factors | With intubation N = 66 | Without intubation N = 59 | P-value | |||
|---|---|---|---|---|---|---|
Cystatin C | 1.48 ± 1.09 | 1.35 ± 0.69 | 0.899 | |||
Creatinine | 1.40 ± 0.94 | 1.35 ± 0.75 | 0.813 | |||
Ferritin (Per 100) | 7.81 ± 3.65 | 4.51 ± 3.89 | < 0.001 | |||
NLR | 6.81 ± 4.88 | 5.46 ± 3.96 | 0.755 | |||
LDH (Per 100) | 7.83 ± 3.19 | 5.49 ± 2.68 | < 0.001 | |||
CRP | 114.95 ± 59.62 | 62 ± 39 | < 0.001 | |||
Demographic | ||||||
Age | 55.86 ± 17.42 | 47.54 ± 20.88 | 0.017 1 | |||
Sex; n (%) | ||||||
 Male | 35(53) | 36(61) | 0.3682 | |||
 Female | 31(47) | 23(39) | ||||
Positive report for smoking | 23(35) | 20(34) | 0.9112 | |||
BMI | 27.86 ± 5.85 | 24.64 ± 4.38 | < 0.001 1 | |||
Positive report for comorbidities | ||||||
 Diabetic | 18(27) | 13(22) | 0.4982 | |||
 Hypertension | 20(30) | 14(24) | 0.4102 | |||
 Dyslipidemia | 25(38) | 9(15) | 0.005 2 | |||
 Cardiovascular disease | 22(33) | 7(12) | 0.005 2 | |||
 Asthma | 11(17) | 12(20) | 0.5972 | |||
 COPD* | 20(30) | 19(32) | 0.8192 | |||
 CKD** | 12(18) | 6(10) | 0.2032 | |||
 Liver diseases | 8(12) | 5(8.50) | 0.5052 | |||